中国临床肿瘤学会(CSCO)白血病专家委员会、淋巴瘤专家委员会及骨髓瘤筹备委员会工作会议暨2024年CSCO血液及淋巴瘤、骨髓瘤疾病学术大会

海口国宾馆

海南省-海口市

2024年01月26-28日

您的位置:首页 > 会议日程
Akihiro Shimosaka
分享到:
Asian Cellular Therapy Organization | 血液内科

Chairperson: Asian Cellular Therapy Organization

Director: Research Foundation for Community Medicine

Honorary Professor: Peking Union Medical College, Hematology Institute

Honorary Professor: Peking University Tumor Hospital

Honorary Professor: The Fourth Military Medical University

Honorary Professor: Heilongjang Institute of Hematology

Tokyo, Japan

R & D for the discovery work in hematology, oncology and immunology

R & D for EPO, G-CSF, TPO, SCF, α-galactosyl ceramide from discovery research, manufacturing, formulation and clinical development

Advisor for Miltenyi Biotec. MaxCyte, Dendreon and Chairman of Anosys for DC therapy, CD133+/CD34+ regenerative therapy and Exosome for immune therapy

NK and NKT cell based cellular therapy

Development of new regulation for cellular therapy

Editorial Board Member for Cytotherapy

Organizing Cellular therapy scientific society based on collaboration among regulatory agency, academy and industry


讲座视频:0

论文摘要:1

21

0

0

日期 时间 会场 Session 角色 讲题
2024-01-27 11:10-11:40 大宴会厅1+2+3

2024年CSCO血液及淋巴瘤、骨髓瘤疾病学术大会

讲者 Points to Consider for Autologous Cellular Therapy